Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 22

Renal tumour

Bernard S. Tjandra
Bedah Urologi
Benign : Haemangioma Fibroma (Jaringan ikat)
Adenoma Lipoma

Malignant :
- Congenital - Nephroblastoma (Wilms) 10 %

- Acquired - Parenchymal Carcinoma 78 %*


Fibrosarcoma
Liposarcoma 2%
- Renal pelvis 10 %
Transitional cell
Squamous cell
Renal cell carcinoma
(Hypernephroma, Clear cell, Grawitz)
- Common in males (1.5 : 1)
- Peak incidence 60 – 70 years
- Highest in N America, Australia, Europe
- Multiple cases 19 %
- Incidence 11 per 100.000 (The Netherlands)
- Present with metastatic 20 – 30 %
Etiology

• Cigarette
• Obesity
• Oestrogen
• Viruses
• Von Hippel-Lindau (40 %)
• Chronic dialysis
• Hereditair ?
Pathology / Histology

Subtypes
Clear cell
Papillary (chromophilic, eosinophilic)
Chromophobic (kromophob lebih ganas daripada
clear cell)
Oncocytic
Collecting duct (Bellini)
Stage !!!!

1 Small, within the capsule


2 Cortex not broken
3a. Perirenal fat
3bV1. Renal vein
3bV2. Vena cava (5 – 9 %)
4. Involvement of adjacent
organs

Pake pemeriksaan Ct / MRI


TNM 2002

• T1 Tumour < 7 cm, limited to the kidney


• T2 Tumour > 7 cm, limited to the kidney
• T3 Tumour extends into major veins or
directly invades adrenal / perinephric
• T4 Tumour directly invades beyond gerota
Clinical manisfestations

• No symptoms (45 %)
• Haematuria, abdominal pain, flank mass (trias)
• Varicocele
• Bone pain
• Pyrexia, weight loss, anorexia, anaemia
• Erythrocytosis
• Hypercalcaemia
Laboratory
• Urine
• Blood (Hb, ESR)
• IVU (stippled calcification, distortion)
• USG of the kidneys
• Chest X-ray
• CT- abdomen using contrast (penting)
• Bone scan
• Selective renal arteriography (neovasculature) Buat tau
• Vena cavography udah
nyebar
kemana
IVU
USG

cyst
C.T of whole abdomen
C.T. Scan
Tumor Thrombus In The Vena Cava
C.T. Scan
Lymph Nodes Metastasis
M.R.I
Treatment
• Radical nephrectomy with / - out lymphadenectomy (20 – 40 %
develop metastases) : masih di dalam parenkim ginjal. Kapsul diangkat.

• Chemotheraphy
- Vinblastine
- Interleukin-2 + alpha interferon +
5-fluorouracil.
- Sorafenib, Sunitinib
• Cryoablation (-20 c)
• Embolization

Tidak ada radioterapi


Modern approaches

• Biological and immune-based therapies


(response rates 15 – 25 %)

Vascular endothelial growth factor (VEGF) Avastin

Staehler, EAU update 2007


Clear cell type
Prognosis

5 – year survival rate


stage 1 50 – 60 %
stage 2 30 – 40 %
stage 3 15 – 30 %
stage 4 3 – 8%
Cryoablation
Recurrence rate 6 – 12.5 %

You might also like